BMRN Biomarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified

BMRN Biomarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome ReNU syndrome was discovered in 2024 and there are no Medicines approved for the condition Collaboration combines Biomarin's leadership in genetic Medicines with n-Lorem's pioneering antisense expertise